Locations:
Search IconSearch
May 18, 2021/Neurosciences/Podcast

Vasculitis and Stroke Before Age 50: A Growing Concern (Podcast)

When to suspect vasculitis and how to treat it

The prevalence of stroke in young adults — those under age 50 — is on the rise. One reason is the increase in atherosclerotic risk factors in this population. Other etiologies include inherited thrombophilias and hypercoagulability disorders, valvular heart disease and — perhaps more notably —autoimmune causes such as vasculitis, which have been on the rise.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The newest episode of Cleveland Clinic’s Neuro Pathways podcast reveals more about stroke in young patients. G. Abbas Kharal, MD, MPH, a cerebrovascular immunologist with Cleveland Clinic’s Neurological Institute, discusses:

  • How to classify cerebral vasculitis
  • When to refer a patient to a cerebrovascular immunologist
  • Brain biopsy, vessel wall imaging and other diagnostic tools
  • Pulse-dose steroids and other treatments
  • Effects of COVID-19 infection in this patient population

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Kharal: When should we suspect vasculitis? It’s important to note when we have the right clinical presentation: a younger patient with headaches, subacute encephalopathy, a subacute decline, recurrent ischemic strokes that really don’t fit in one specific cerebrovascular territory, and other constitutional symptoms. That is when to think that there’s something inflammatory going on.

The initial tests that lead us to diagnose a vasculopathy are, first, a brain MRI showing that there are new ischemic infarcts, and then some sort of vessel imaging, be it a CTA or MRA, that can demonstrate if there is a vasculopathy at all. Often you’ll be able to identify large- and medium-sized vessels on a CTA or MRA. However, smaller vessels, particularly those that are a couple of hundred micrometers in diameter, the tertiary and quaternary branches, are better visualized on cerebral angiography or DSA [digital subtraction angiography].

Advertisement

Once you have imaging showing vessel irregularities and CT or MRI evidence of new acute infarcts, you’ve established that there is some form of vasculopathy. But you still have not diagnosed whether or not it is inflammatory! That’s a common mistake I see clinicians make. Someone will do an angiogram and see vascular irregularities and say, “This is suggestive of vasculitis.” However, all we can tell on an angiogram or any vessel imaging is whether or not there is a vasculopathy.

The presence of vasculitis requires either an inflammatory CSF or tissue diagnosis — or, particularly in secondary causes, elevated inflammatory markers or other inflammatory signs and symptoms.

Once you’ve established a diagnosis of inflammatory vasculitis, that is when you want to further determine whether it is primary or secondary.

Advertisement

Related Articles

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

Ad